STAN S31 Fetal Heart Monitor
PMA P020001
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP020001 | Date1 Nov 2005 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Generic Name
- Analyzer, data, obstetric
- PMA Number
- FDA Product Code
- HEO
- Device Class
- Class III
- Regulation
- 21 CFR Part 884.2050
- Advisory Committee
- Obstetrics/Gynecology
- FDA Decision
- APPR Approved
Overview
AI-generated summary, 18 Sep 2026
The STAN S31 Fetal Heart Monitor is an obstetric data analyzer indicated as an adjunct to fetal heart rate monitoring to determine whether obstetrical intervention is warranted when there is increased risk of developing metabolic acidosis. It is intended for use in patients with planned vaginal delivery, greater than 36 completed weeks gestation, singleton fetus, vertex presentation, and ruptured amniotic membranes.
The device is authorized under FDA PMA (P020001) and classified as a Class III obstetric data analyzer. It is manufactured by Neoventa Medical AB in Molndal, Sweden, and is intended for use in clinical settings during labor under the specified patient criteria.
Other devices from Neoventa Medical AB
Questions
AI-generated answers, 18 Sep 2026
What is the STAN S31 Fetal Heart Monitor used for?
The STAN S31 Fetal Heart Monitor is used as an adjunct to fetal heart rate monitoring to help determine whether obstetrical intervention is warranted when there is an increased risk of developing metabolic acidosis in the fetus during labor.
Who manufactures the STAN S31 Fetal Heart Monitor?
The STAN S31 Fetal Heart Monitor is manufactured by Neoventa Medical AB, located at Norra Agatan 32, Molndal, SE-431 35, Sweden.
What regulatory authorization does the STAN S31 Fetal Heart Monitor have?
The STAN S31 Fetal Heart Monitor has received FDA Premarket Approval (PMA) under PMA number P020001, with approval granted on November 1, 2005.